ArticleDisease markers2019

CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages.

Zhiheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.